Identification and Clinical Correlation Analysis of IFI44 in Systemic Lupus Erythematosus Combined with Bioinformatics and Immune Infiltration Analysis
Yuan Wang,Chengfeng Ma,Zhanbing Ma,Mengyi Yang,Jing Pu,Xiuhui Ma,Xi Wu,Liang Peng,Zhenghao Huo,Jie Dang
DOI: https://doi.org/10.2147/JIR.S419880
IF: 4.5
2023-08-02
Journal of Inflammation Research
Abstract:Yuan Wang, 1– 3 Chengfeng Ma, 1, 2 Zhanbing Ma, 1, 2 Mengyi Yang, 1, 2 Jing Pu, 1, 2 Xiuhui Ma, 1, 2 Xi Wu, 1, 2 Liang Peng, 1, 2 Zhenghao Huo, 1, 2, &ast Jie Dang 1, 2, &ast 1 School of Basic Medicine, Ningxia Medical University, Yinchuan, Ningxia, People's Republic of China; 2 Key Laboratory of Fertility Preservation and Maintenance of the Ministry of Education, Ningxia Medical University, Yinchuan, Ningxia, People's Republic of China; 3 Department of Dermatology, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, People's Republic of China &astThese authors contributed equally to this work Correspondence: Jie Dang; Zhenghao Huo, Department of Medical Genetics and Cell Biology, School of Basic Medicine, Ningxia Medical University, 1160 Shengli Street, Yinchuan, Ningxia, 750001, People's Republic of China, Tel/Fax +86-951-6980049, Email Purpose: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can cause systemic damage to multiple organs. This study aims to analyze the value and function of IFI44 in the diagnosis and pathology of SLE by bioinformatics and immune infiltration analysis. Patients and Methods: GSE49454 and GSE65391 of SLE were obtained from the GEO dataset, and R software was employed to identify DEGs and investigate their functions. The PPI network was utilized to identify hub genes associated with SLE. CIBERSORT was used to assess differences in immune cell infiltration in SLE patients and controls. ROC curve analysis was performed to evaluate the diagnostic value of IFI44 in SLE. The expression of IFI44 in PBMCs was detected by RT-qPCR, and the correlation between IFI44 expression and SLE-related clinical indicators was analyzed. Results: A total of 65 DEGs were identified from the GSE49454 and GSE65391 databases. Through PPI analysis, IFI44 and RSAD2 were identified as significantly aberrantly expressed in SLE patients. SLE patients and controls showed a significant difference in the proportion of immune cell infiltration. IFI44 expression was positively correlated with activated DCs, monocytes, PCs, neutrophils, and activated memory CD4 + T cells, while negatively correlated with M0 and CD8 + T cells. The expression of IFI44 was significantly higher in SLE patients ( P < 0.01), especially in male patients ( P =0.0376). ROC curve analysis demonstrated that IFI44 had a high diagnostic value for SLE. Correlation analysis indicated that IFI44 expression was correlated with levels of RBC, HGB, HCT, IgA, ESR, UPRO, C3, C4, and ENA in SLE patients. Conclusion: IFI44 may play a role in the pathogenesis of SLE by influencing the immune microenvironment of SLE patients, and thus has the potential to serve as a diagnostic marker and therapeutic target for SLE. Keywords: systemic lupus erythematosus, IFI44 , bioinformatics, immune cell infiltration, sexual dimorphism Systemic lupus erythematosus (SLE) is an autoimmune disease in which the immune system attacks the body's own tissues, causing widespread inflammation and tissue damage in affected organs. SLE is most commonly diagnosed between the ages of 20 and 30, with a male-to-female ratio of 1:9. 1 Incidence and prevalence of SLE vary widely among different geographic regions, with the highest reported rates in North America and the lowest in Africa and Australia. 2 Although the exact cause of SLE is not well understood, it is known to involve a complex interaction of environmental, genetic, and epigenetic factors. 3 Treatment for SLE patients depends on the presentation and activity of the disease, with the ultimate goal of achieving remission or reducing disease activity through various immunoregulatory and immunosuppressive therapies. Strong activation of complement and production of type I interferon (IFN) are key factors in the pathogenesis of SLE. Type I IFN promote immune response activation to nucleic acids and their associated proteins, resulting in autoantibody production, immune complex formation, and organ inflammation. 4 Patients with elevated type I IFN signatures are more likely to develop lupus nephritis, which is inflammation of the kidneys that can lead to impaired function and kidney failure. 5 Several cross-sectional studies have shown that IFN markers are associated with disease activity and severe SLE involving the kidneys, hematopoietic system, and nervous -Abstract Truncated-
immunology